Association of plasma homocysteine with coronary artery calcification in different categories of coronary heart disease risk

Iftikhar Jan Kullo, Guo Li, Lawrence F. Bielak, Kent R Bailey, Patrick F. Sheedy, Patricia A. Peyser, Stephen T Turner, Sharon L R Kardia

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

OBJECTIVE: To investigate the association of plasma homocysteine with coronary artery calcification (CAC) in strata based on 10-year risk of coronary heart disease (CHD) in a cohort enriched in persons with hypertension. PARTICIPANTS AND METHODS: Fasting plasma homocysteine was measured by liquid chromatography electrospray tandem mass spectrometry. Coronary artery calcification was measured non-invasively by electron beam computed tomography and CAC score calculated using the method of Agatston et al. The 10-year CHD risk was calculated based on the Framingham risk score. The association of homocysteine with log-transformed CAC score was assessed in the pooled sample and within each risk stratum by linear regression after adjustment for conventional risk factors. RESULTS: In the 1071 participants studied, homocysteine was associated with CAC quantity (P=.01) after adjustment for CHD risk factors (age, male sex, total and high-density lipoprotein cholesterol, diabetes, history of smoking, body mass index, and systolic blood pressure), serum creatinine, and statin and hypertension medication use. When the association was assessed in strata based on 10-year CHD risk, homocysteine was significantly (P=.003) associated with CAC quantity in participants at intermediate 10-year risk of CHD (6%-20%) independent of other risk factors but not in those at lower risk or higher risk. CONCLUSION: Plasma homocysteine is associated with quantity of CAC independent of CHD risk factors. When studied in categories of 10-year CHD risk, the association was significant in participants at intermediate risk but not in those at low or high risk. Plasma homocysteine levels may have clinical utility as a marker of CHD risk in such individuals.

Original languageEnglish (US)
Pages (from-to)177-182
Number of pages6
JournalMayo Clinic Proceedings
Volume81
Issue number2
DOIs
StatePublished - 2006

Fingerprint

Homocysteine
Coronary Disease
Coronary Vessels
Blood Pressure
Hypertension
Hydroxymethylglutaryl-CoA Reductase Inhibitors
X Ray Computed Tomography
Tandem Mass Spectrometry
Liquid Chromatography
HDL Cholesterol
Linear Models
Fasting
Creatinine
Body Mass Index
Smoking

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Association of plasma homocysteine with coronary artery calcification in different categories of coronary heart disease risk. / Kullo, Iftikhar Jan; Li, Guo; Bielak, Lawrence F.; Bailey, Kent R; Sheedy, Patrick F.; Peyser, Patricia A.; Turner, Stephen T; Kardia, Sharon L R.

In: Mayo Clinic Proceedings, Vol. 81, No. 2, 2006, p. 177-182.

Research output: Contribution to journalArticle

Kullo, Iftikhar Jan ; Li, Guo ; Bielak, Lawrence F. ; Bailey, Kent R ; Sheedy, Patrick F. ; Peyser, Patricia A. ; Turner, Stephen T ; Kardia, Sharon L R. / Association of plasma homocysteine with coronary artery calcification in different categories of coronary heart disease risk. In: Mayo Clinic Proceedings. 2006 ; Vol. 81, No. 2. pp. 177-182.
@article{5e31de6d40364a6a8e18663cb5907d1f,
title = "Association of plasma homocysteine with coronary artery calcification in different categories of coronary heart disease risk",
abstract = "OBJECTIVE: To investigate the association of plasma homocysteine with coronary artery calcification (CAC) in strata based on 10-year risk of coronary heart disease (CHD) in a cohort enriched in persons with hypertension. PARTICIPANTS AND METHODS: Fasting plasma homocysteine was measured by liquid chromatography electrospray tandem mass spectrometry. Coronary artery calcification was measured non-invasively by electron beam computed tomography and CAC score calculated using the method of Agatston et al. The 10-year CHD risk was calculated based on the Framingham risk score. The association of homocysteine with log-transformed CAC score was assessed in the pooled sample and within each risk stratum by linear regression after adjustment for conventional risk factors. RESULTS: In the 1071 participants studied, homocysteine was associated with CAC quantity (P=.01) after adjustment for CHD risk factors (age, male sex, total and high-density lipoprotein cholesterol, diabetes, history of smoking, body mass index, and systolic blood pressure), serum creatinine, and statin and hypertension medication use. When the association was assessed in strata based on 10-year CHD risk, homocysteine was significantly (P=.003) associated with CAC quantity in participants at intermediate 10-year risk of CHD (6{\%}-20{\%}) independent of other risk factors but not in those at lower risk or higher risk. CONCLUSION: Plasma homocysteine is associated with quantity of CAC independent of CHD risk factors. When studied in categories of 10-year CHD risk, the association was significant in participants at intermediate risk but not in those at low or high risk. Plasma homocysteine levels may have clinical utility as a marker of CHD risk in such individuals.",
author = "Kullo, {Iftikhar Jan} and Guo Li and Bielak, {Lawrence F.} and Bailey, {Kent R} and Sheedy, {Patrick F.} and Peyser, {Patricia A.} and Turner, {Stephen T} and Kardia, {Sharon L R}",
year = "2006",
doi = "10.4065/81.2.177",
language = "English (US)",
volume = "81",
pages = "177--182",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "2",

}

TY - JOUR

T1 - Association of plasma homocysteine with coronary artery calcification in different categories of coronary heart disease risk

AU - Kullo, Iftikhar Jan

AU - Li, Guo

AU - Bielak, Lawrence F.

AU - Bailey, Kent R

AU - Sheedy, Patrick F.

AU - Peyser, Patricia A.

AU - Turner, Stephen T

AU - Kardia, Sharon L R

PY - 2006

Y1 - 2006

N2 - OBJECTIVE: To investigate the association of plasma homocysteine with coronary artery calcification (CAC) in strata based on 10-year risk of coronary heart disease (CHD) in a cohort enriched in persons with hypertension. PARTICIPANTS AND METHODS: Fasting plasma homocysteine was measured by liquid chromatography electrospray tandem mass spectrometry. Coronary artery calcification was measured non-invasively by electron beam computed tomography and CAC score calculated using the method of Agatston et al. The 10-year CHD risk was calculated based on the Framingham risk score. The association of homocysteine with log-transformed CAC score was assessed in the pooled sample and within each risk stratum by linear regression after adjustment for conventional risk factors. RESULTS: In the 1071 participants studied, homocysteine was associated with CAC quantity (P=.01) after adjustment for CHD risk factors (age, male sex, total and high-density lipoprotein cholesterol, diabetes, history of smoking, body mass index, and systolic blood pressure), serum creatinine, and statin and hypertension medication use. When the association was assessed in strata based on 10-year CHD risk, homocysteine was significantly (P=.003) associated with CAC quantity in participants at intermediate 10-year risk of CHD (6%-20%) independent of other risk factors but not in those at lower risk or higher risk. CONCLUSION: Plasma homocysteine is associated with quantity of CAC independent of CHD risk factors. When studied in categories of 10-year CHD risk, the association was significant in participants at intermediate risk but not in those at low or high risk. Plasma homocysteine levels may have clinical utility as a marker of CHD risk in such individuals.

AB - OBJECTIVE: To investigate the association of plasma homocysteine with coronary artery calcification (CAC) in strata based on 10-year risk of coronary heart disease (CHD) in a cohort enriched in persons with hypertension. PARTICIPANTS AND METHODS: Fasting plasma homocysteine was measured by liquid chromatography electrospray tandem mass spectrometry. Coronary artery calcification was measured non-invasively by electron beam computed tomography and CAC score calculated using the method of Agatston et al. The 10-year CHD risk was calculated based on the Framingham risk score. The association of homocysteine with log-transformed CAC score was assessed in the pooled sample and within each risk stratum by linear regression after adjustment for conventional risk factors. RESULTS: In the 1071 participants studied, homocysteine was associated with CAC quantity (P=.01) after adjustment for CHD risk factors (age, male sex, total and high-density lipoprotein cholesterol, diabetes, history of smoking, body mass index, and systolic blood pressure), serum creatinine, and statin and hypertension medication use. When the association was assessed in strata based on 10-year CHD risk, homocysteine was significantly (P=.003) associated with CAC quantity in participants at intermediate 10-year risk of CHD (6%-20%) independent of other risk factors but not in those at lower risk or higher risk. CONCLUSION: Plasma homocysteine is associated with quantity of CAC independent of CHD risk factors. When studied in categories of 10-year CHD risk, the association was significant in participants at intermediate risk but not in those at low or high risk. Plasma homocysteine levels may have clinical utility as a marker of CHD risk in such individuals.

UR - http://www.scopus.com/inward/record.url?scp=32144440861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32144440861&partnerID=8YFLogxK

U2 - 10.4065/81.2.177

DO - 10.4065/81.2.177

M3 - Article

VL - 81

SP - 177

EP - 182

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 2

ER -